Adenocarcinoma of the Rectum Completed Phase 1 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0028688 (Adenocarcinoma of the Rectum)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00028496Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerTreatment